Top Back to top

Fusarium infections in allogeneic hematopoietic cell transplant recipients

Infectious Diseases Working Party (IDWP)
Study type:
Study number:
Type of Stem Cell Treatment:
Complications: infectious
Short title:
Primary objective:
1) to describe the clinical, radiological and microbiological characteristics of Fusarium infections in allo-HCT patients;
2) to identify risk factors for Fusarium infections in allo-HCT patients, including antifungal prophylaxis.

Secondary objectives:
1) to assess the clinical outcome after Fusarium infection (all-cause mortality at 6 weeks);
2) to assess risk factors associated with mortality after Fusarium infection
3) to assess incidence of invasive fusariosis
Key inclusion criteria:
All allogeneic HSCT recipients who developed proven or probable Fusarium infection between 01 January 2010 and 31 May 2023 (irrespective of patient age, underlying disease or transplant date).
All EBMT member countries
Principal investigator:
Dina Averbuch
EBMT Study coordinator:
Lotus Wendel
Study coordinator email:
EBMT Study Unit:
Leiden Study Unit
Reason for processing personal data:
Research and Development of new and improved transplant, cell therapy and immunosuppression procedures.
Categories of personal data collected:
DOB/YOB, gender
Medical data already reported to the EBMT Registry
Study Specific Questionnaire (MED-C)
Recipients who may access the data:
Leiden Study Unit
Statistical Unit
3rd-party processors of Personal Data on behalf of EBMT/Service provider:

Privacy notices

Article 6 lawful basis for processing personal data:
Article 6.1 (a) - Consent (Collection)
Article 9 basis for processing special category data:
Article 9(2) (a) - Consent (Collection)

Data Protection Impact Assessments

Rights available to individuals:
Data portability
Is a Data Protection Impact Assessment required?:
DPIA performed for EBMT Registry (WP & NIS Studies)
Retention Schedule (if possible):
at least 5 years after the final report or first publication of study results